Skip to main content

Harrison Silvers

Head of Investor Relations

UNITED THERAPEUTICS Corp (UTHR)

Equibles does not estimate personal net worth.

Get an email with a short summary when UNITED THERAPEUTICS Corp publishes a filing, an earnings call transcript or a press release.

Get UTHR alerts

About Harrison Silvers

Harrison Silvers is recorded as Head of Investor Relations at UNITED THERAPEUTICS Corp (UTHR). Harrison Silvers has spoken on 2 earnings calls and 2 other investor events across 1 company, most recently for UNITED THERAPEUTICS Corp on August 5, 2026. UNITED THERAPEUTICS Corp is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at UNITED THERAPEUTICS Corp includes Christopher Causey (Board Member), Christopher Patusky (Board Member), James Edgemond (Board Member) and 7 others.

Harrison Silvers on recent calls

“It is my pleasure to welcome you to the United Therapeutics Corporation's second quarter 2026 corporate update webcast. Remarks today will include forward-looking statements representing our expectations or beliefs regarding future events.”
Head of Investor Relations, UNITED THERAPEUTICS Corp Q2 FY2026 Earnings Call ·
“Today we may make some forward-looking statements, and for any risks and uncertainties associated with those statements, would encourage you to look at our latest SEC filings on Forms 10-K and 10-Q.”
Head of Investor Relations, Jefferies Global Healthcare Conference ·
“First of all, it's great to see at ATS the community come together in pursuit of better outcomes for patients. Just a really great energy there overall, and particularly in our two breaking news sessions, which were accepted in the clinical trial session on Sunday.”
Head of Investor Relations, RBC Capital Markets Global Healthcare Conference ·
“It is my pleasure to welcome you to the United Therapeutics Corporation First Quarter 2026 Corporate Update Webcast. Remarks today will include forward-looking statements representing our expectations or beliefs regarding future events.”
Head of Investor Relations, UNITED THERAPEUTICS Corp Q1 FY2026 Earnings Call ·

Affiliation history

Company network

Leadership on record at UNITED THERAPEUTICS Corp

Recent activity